Metagenomi, Inc. (MGX)
NASDAQ: MGX · Real-Time Price · USD
1.740
+0.020 (1.16%)
Dec 24, 2025, 1:00 PM EST - Market closed
Metagenomi Market Cap
Metagenomi has a market cap or net worth of $65.33 million as of December 24, 2025. Its market cap has decreased by -58.14% in one year.
Market Cap
65.33M
Enterprise Value
-77.12M
1-Year Change
-58.14%
Ranking
Category
Stock Price
$1.74
Market Cap Chart
Since the IPO on February 9, 2024, Metagenomi's market cap has decreased from $562.92M to $65.33M, a decrease of -88.39%. That is a compound annual growth rate of -68.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 24, 2025 | 65.33M | -51.64% |
| Dec 31, 2024 | 135.10M | -76.00% |
| Feb 9, 2024 | 562.92M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 964.31B |
| Johnson & Johnson | 500.60B |
| AbbVie | 406.30B |
| UnitedHealth Group | 296.73B |
| AstraZeneca | 286.29B |
| Novartis AG | 267.64B |
| Merck & Co. | 264.21B |
| Novo Nordisk | 232.28B |